They observed a significant reduction in the homeostatic microglial markers P2RY12 and transmembrane protein 119 (TMEM119), along with elevated levels of disease-associated markers ferritin heavy chain (FTH1) and TREM2 in AD patients’ MDEs. This evidence concerns the gene TMEM119 and Alzheimer disease.